Dan Jin Wang

Director/Board Member at YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD.

Net worth: 93 419 $ as of 2024-03-30

54 year

Health Technology

Consumer Services

Profile

Dan Jin Wang is currently working as an Executive Director & Deputy General Manager at YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
and as a Director at HEC Pharm Co., Ltd.
He completed his undergraduate degree from Shenyang Pharmaceutical University in 2008.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
YICHANG HEC CHANGJIANG PHARMACEUTICAL CO. LTD. CLASS H 0.01%	2023-06-29	67,200 ( 0.01% )	93 419 $	2024-03-30

Dan Jin Wang active positions

Companies	Position	Start
YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD.	Director/Board Member	2006-02-26
HEC Pharm Co., Ltd. HEC Pharm Co., Ltd. Pharmaceuticals: MajorHealth Technology Yichang Dongyang Changjiang Pharmaceuical Co. Ltd. manufactures pharmaceutical products. The Company mainly develops, produces, and distributes active pharmaceutical ingredients and insulins. The firm focuses on anti-virus, endocrine and metabolic diseases and cardiovascular diseases. The company was founded on August 08, 2001and is headquartered in Dongguan, China.	Director/Board Member	-

All active positions of Dan Jin Wang

Training of Dan Jin Wang

Shenyang Pharmaceutical University

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Dan Jin Wang's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD.	Health Technology

Private companies	1
HEC Pharm Co., Ltd. HEC Pharm Co., Ltd. Pharmaceuticals: MajorHealth Technology Yichang Dongyang Changjiang Pharmaceuical Co. Ltd. manufactures pharmaceutical products. The Company mainly develops, produces, and distributes active pharmaceutical ingredients and insulins. The firm focuses on anti-virus, endocrine and metabolic diseases and cardiovascular diseases. The company was founded on August 08, 2001and is headquartered in Dongguan, China.	Health Technology